DBVT DBV Technologies Future Profit

DBVT (DBV Technologies SA) - company brandmark

DBV Technologies S.A. (DBVT) creates unique epidermal patches to combat allergies, laying the foundation for expansion. Analyst earnings expectations confirm this potential, and 0.01 captures the magnitude of this parameter. Financial stability currently depends on cash reserves and regulatory verdicts. The environmental profile is limited by strict compliance with laboratory standards for biomaterial disposal.

DBV Technologies SA (DBVT): Company Profit Forecast from 10/30/2025 to 10/31/2025

DBVT (DBV Technologies SA): analytical breakdowns and indicator data

- share price and consensus valuation forecast:
Stock Price DBV Technologies SA|DBVT - Analyst Consensus Forecast
- market capitalization data:
Market Valuation DBV Technologies SA|DBVT - Value Adjusted for Debt and Cash
- book capitalization information:
Net Assets per Single Share DBV Technologies|DBVT - Book Valuation of Business|Market Value to Book Value Ratio dbv-technologies.com|DBVT - Company Total Assets
- company total debt and liquidity indicators:
Total Debt to Capital DBV Technologies S.A.|DBVT - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity DBV Technologies|DBVT - Company Aggregate Debt|Debts to Book Capitalization DBV Technologies S.A.|DBVT - Company Long-Term Indebtedness|Company Short-Term Debts DBV Technologies|Quick Liquidity Indicator dbv-technologies.com
- net income and valuation ratios data:
DBVT - Company Net Income|Future Profit DBV Technologies S.A.|DBVT - Company Value to Net Income|Projected Price to Earnings DBV Tech|DBVT - Company Value to Earnings Growth Ratio|EV/EBITDA Multiple DBV Technologies|DBVT - Profit before interest, taxes and amortization|Net earnings per share (EPS TTM) DBV Technologies|DBVT - Net earnings per share for the last 12 months|Quarterly EPS earnings growth dbv-technologies.com|DBVT - Earnings per share increase in current year|Net earnings per share growth forecast for next year DBV Technologies S.A.
- revenue and sales details:
DBVT - Company Sales Volume|Company Projected Revenue DBV Tech|DBVT - Price to Sales|Price-to-Projected Revenue Ratio DBV Tech
General company analysis:DBV Technologies SA, DBVT
Finished products of DBV Tech

Earnings forecasts for DBV Technologies S.A. (DBVT) are critically important, as they allow for an assessment of the viability of patches under pressure from more convenient oral medications produced by pharmaceutical behemoths. By analyzing the forward earnings chart, an investor can identify hidden costs and trend inertia, avoiding overpayment for artificially smoothed margin dynamics, which provides an objective assessment of business resilience within a hyper-competitive niche.

Competing companies

KRYS (krystalbio.com) - Projected Future Earnings|Projected Future Earnings Apogee Pharma|Future Profit ARQT (Arcutis Biotherapeutics Inc)|VCEL (Vericel Inc.) - Expected Net Income|Expected Profit orukatx.com ORKA|Company Profit Forecast Sanara MedTech Inc. (SMTI)|SLSN - Expected Profit|DERM - Projected Future Earnings|FBRX: Projected Future Earnings|EMPG - Company Profit Forecast|Expected Profit Sol-Gel Technologies Ltd.|Net Profit Forecast AXIL (AXIL Brands, Inc.)|Expected Profit Medicus Pharma Ltd (MDCX)|Expected Profit VRCA (Verrica Pharmaceuticals Inc.)|Expected Profit Hoth Therapeutics HOTH|Company Profit Forecast Biofrontera Inc. (BFRI)|VYNE - Expected Profit|SNOA (Sonoma Pharmaceuticals, Inc.) - Net Profit Forecast|QNRX: Projected Future Earnings|AZTR: Future Net Profit|DRMA (Dermata Therapeutics Inc) - Projected Future Earnings|Projected Future Earnings Elevai Skincare|Projected Future Earnings RVNC